cysteamine has been researched along with sq-23377 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goldstone, SD; Hunt, NH | 1 |
| Dunn, TM; Pontzer, CH; Taub, FE; Wormsley, S | 1 |
| Izquierdo, D; Jiménez, AR; Paramio, MT; Urdaneta, A | 1 |
3 other study(ies) available for cysteamine and sq-23377
| Article | Year |
|---|---|
Redox regulation of the mitogen-activated protein kinase pathway during lymphocyte activation.
Topics: Alkaloids; Antioxidants; Benzophenanthridines; Calcium-Calmodulin-Dependent Protein Kinases; Cell Division; Cyclosporine; Cysteamine; DNA-Binding Proteins; Humans; Interphase; Ionomycin; Jurkat Cells; Lymphocyte Activation; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Monocytes; Phenanthridines; Reactive Oxygen Species; Signal Transduction; T-Lymphocytes; Tetradecanoylphorbol Acetate; Transcription Factor AP-1 | 1997 |
Increased T cell cytotoxicity by Betathine-induced upregulation of TNFalpha.
Topics: Adjuvants, Immunologic; Antigens, CD; Antineoplastic Agents; Cysteamine; Cytotoxicity, Immunologic; Dose-Response Relationship, Drug; Humans; Ionomycin; Monocytes; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; RNA, Messenger; T-Lymphocytes; Tetradecanoylphorbol Acetate; Time Factors; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2000 |
Cysteamine, glutathione and ionomycin treatments improve in vitro fertilization of prepubertal goat oocytes.
Topics: Animals; Cysteamine; Embryo, Mammalian; Fertilization in Vitro; Glutathione; Goats; Ionomycin; Oocytes; Sperm Capacitation | 2004 |